Kenacort
Drug - Kenacort
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Triamcinolone
Multiple ingredients are in alphabetical order.
Strength -
4MG
The potency of the active ingredient(s), Triamcinolone. May repeat for multiple part products.
Applicant -
BRISTOL MYERS SQUIBB
The firm name holding legal responsibility for Kenacort. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
011283
The FDA assigned number to Kenacort. Format is nnnnnn.
Product Number -
006
The FDA assigned number to identify Kenacort. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
BP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Kenacort was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Kenacort. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Kenacort is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Bristol Myers Squibb Co
The full name of the firm holding legal responsibility for the new application of Kenacort.
Kenacort
|
